7th SCS-Syngenta Symposium 2024

Welcome to the 7^th edition of the SCS-Syngenta Symposium: "Unlocking Innovation through Chemical Biology"

This exciting event will feature the latest advances in Chemical Biology, covering drug target validation and mode of action elucidation, chemical inducers of proximity for protein degradation and beyond, mechanistic investigations of cellular processes and drug discovery success stories enabled by Chemical Biology. We look forward to exploring together opportunities to innovate across scientific disciplines and create breakthrough discoveries that address the biggest challenges of our times. The lunchtime poster session will provide an excellent opportunity for participants to exchange ideas and strengthen the links between industrial research and academic laboratories.

Poster presenters automatically participate in the Best Presentation Award Program sponsored by Helvetica Chimica Acta. Helvetica will honor two winners in the category Best Poser Presentation with a certificate and 100CHF cash each.

Photo slide show from the last on site SCS-Syngenta Symposium in 2019

Speakers

Prof. Patrick Barth,
EPFL Lausanne, CH

Prof. Gonçalo Bernardes,
University of Cambridge, UK

Dr. Thais Gazzi,
F. Hoffmann-La Roche, Basel, CH

Prof. Denis Gillingham,
University of Basel, CH

Prof. Stephan Hacker,
University of Leiden, NL

Dr. Scott Lovell,
University of Bath, UK

Dr. Philipp Ottis,
Novartis Biomedical Research Basel, CH

Dr. Slava Ziegler,
Max Planck Institute of Molecular Physiology, Dortmund, DE

Lecture hall at Sygenta Research Center in Stein during the SCS-Syngenta Symposium 2019

Information / Warning to be careful

To all participants, speakers and invited guests:
Please note that requests for any organizational issues will only be made by OC members of the event or the SCS Head Office (...@scg.ch). We do not collaborate with travel agencies that claim to book travel and accommodation on our behalf. In case of any uncertainty, please contact info@scg.ch and make sure that there is no fraudulent activity going on.